Volumat MC Agilia is the advanced volumetric infusion pump in the Agilia Range, the new family of intuitive infusion devices developed by Fresenius Kabi, based in Brézins, France.
Infusion technology has come a long way in the past decade, explains Stéphane Ruton, Director of Strategic Marketing for IV Technology at Fresenius Kabi, which focuses on infusion therapies and clinical nutrition, as well as the respective medical devices.
While Western Europe's hospitals only carry out drills for possible terrorist events — Israel's medics face the real thing. During the recent Congress of Anaesthesiology and Intensive Care Medicine in Berlin, internist Dr Michael Kafka, head of emergency medicine at the Bnai Zion Medical Centre in Haifa, described strategies to cope with mass casualty events.
The Swiss charity EurAsia Heart, founded in 2006 by cardiac surgeon Professor Paul Vogt MD, at Zurich University Hospital, emerged from numerous contacts being made with Asian heart surgeons at the beginning of 2000, and consequent invitations to perform surgery and lecture tours in China.
Injections, that's everyday business for the men and women working in healthcare. As long as it is the patients who have to face the needle, it seems. Like in the years before Dr Heinzpeter Moecke, medical director of Asklepios Klinik Nord-Heidberg in Hamburg, Germany, set an example for his staff and had a vaccination.
Theatre management is one of the most challenging jobs in a hospital. Picis offers a solution: Recently it has launched the Picis Perioperative Dashboard, a Business Intelligence (BI) solution for the perioperative areas of the hospitals in Europe.
Transapical aortic valve implantation (TA-AVI) is a new therapeutic strategy, which has been implemented successfully into clinical practice in several hundred patients suffering symptomatic aortic stenosis and an increase perioperative risk during the past two years. The Edwards SAPIEN™ prosthesis has been used.
For half a century, day after day, Dräger's Vapor has saved lives. Yet no patient knows this. Only the anaesthetist and surgical team can be fully aware of its value in keeping their patients unconscious and pain free during surgery, Dräger reports proudly, in the 50th year of Vapor's service.
Syncope (fainting) is a leading cause of hospital emergency visits. In almost 10% of patients, syncope has a cardiac cause; in 50%, a non-cardiac cause, and in 40% the cause of syncope is unknown. Syncope is difficult to diagnose as syncopal episodes are often too infrequent and unpredictable for detection with conventional monitoring techniques.
Ever since Boston surgeon John Collins Warren commented on the first successful ether anaesthesia at Harvard University with the now famous words, ‘Gentlemen, this is no humbug!’ anaesthesiology has developed into a separate and modern medical discipline.
Magnetic Resonance Guided Focused Ultrasound (MRgFUS) therapy was introduced in June at the Amperklinikum in Dachau, near Munich, the third German site, after Berlin and Bochum for this new technology.
"Surgical care and its safe delivery affect the lives of millions of people. About 234 million major operations are performed worldwide every year", according to the World Health Organization (WHO). To avoid - possibly fatal - complications the WHO introduced a checklist on safe surgery.
Day after day it saves lifes. Since fifty years. But no rescued person knows it. Only the anesthesist and the surgery team. For more than half a century Dräger Vapor® liquid-anesthetic supports them in enabling patients to remain unconscious and pain free during surgery.
Russian surgeons perform cardiac autotransplantation to treat giant left atrium, severe mitral and tricuspid regurgitation
Arrythmogenic remodelling of the left atrium is a common complication of atrial fibrillation, leading to severe haemodynamic disturbances.
Draeger reports that the Apollo includes an advanced ventilation capability that provides ICU quality ventilation in the operating theatre (OT), as well as
GE Healthcare has received the CE mark for its Centricity Clinical Information Systems (CIS), Centricity Anaesthesia and Centricity Critical Care as a medical device according to the European Union Medical Device Directive (MDD)93/42/EEC.
Since its early beginnings in Europe, during the polio epidemics of the 1950s, intensive care medicine has grown to become a specialty in its own right and the intensive care unit (ICU) occupies an increasingly important position in every hospital. Intensive care doctors are responsible for the management of very sick patients often with multiple and complex disease processes, and ICUs are now…
A new plaster combines an innovative warming system with the two potent anaesthetics lidocaine and tetracaine. The warming of the skin increases vasodilatation and the blood vessel permeability, which accelerates the drug administration. EUSA Pharma's new product eliminates pain in 95% of patients after 30 minutes, providing a fast and effective surface anaesthesia of the skin.
MAQUET Critical Care today announced the introduction of MAQUET FLOW-i, the company's new anesthesia system, at the world's largest medical trade fair, MEDICA 2007.
The newest member of the Fabius family of Dräger Medical AG & Co. KG, was designed especially for the requirements in Magnetic Resonance Imaging (MRI). The system is also suitable for other applications involving magnetic fields such as a cardiac catheterisation laboratory or proton therapy.
In May 2001, the world's first CT-XR hybrid suite for image guided therapy in paediatrics was put into operation. The new Centre for Image Guided Therapy (IGT) at The Hospital for Sick Children allows surgeons and interventional radiologists to do something that's never been done before - work side-by-side when diagnosing and treating children. A total of 4 interventional suites were equipped…
Natural orifice transluminal endoscopic surgery (NOTES - a technique that could revolutionize minimally invasive surgery (MIS) by eliminating abdominal incisions - is slowly shifting from research on animal models to human patients.
The US Food and Drug Administration (FDA) has given 510(K) clearance to Maquet Critical Care of Solna, Sweden, to market its Servo-i ventilator with the NAVA (Neurally Adjusted Ventilatory Assist) option. Sales of the system, which aims to treat and monitor neonatal, infant and adult patients, should begin this year. In addition, current Servo-i users can upgrade their system with NAVA.
i-gel, a new single-use, supraglottic airway device designed for quick, easy insertion, also comes ready to use.
'Ultrasound-guided interventional pain therapy originates in ultrasound guided regional anaesthesia,' Dr Eichenberger explained.